Bill Snyder Archive — Page 121 of 121

Multiple blue-toned sagittal MRI scans of the human brain arranged together, with white technical labels overlaid.
March 11, 2011

Neuroscience drug discovery center opens at Vanderbilt

Vanderbilt University Medical Center has established a new Center for Neuroscience Drug Discovery to accelerate research that may lead to new treatments for Parkinson’s disease, schizophrenia and other disorders of the brain.

By Bill Snyder
February 25, 2010

Two Vanderbilt scientists win Sloan research fellowships

Physicist Andreas Berlind and human geneticist Marylyn Ritchie at Vanderbilt University have each won two-year, $50,000 research fellowships from the Alfred P. Sloan Foundation aimed at encouraging promising young scholars.

By Bill Snyder
October 21, 2009

Vanderbilt scientists receive federal funding for two unconventional research projects

Figuring out how biological clocks evolved and extracting clues to environmental factors that cause cancer from electronic medical records: These are the goals of two projects that have been funded by a National Institutes of Health (NIH) program.

By Bill Snyder
February 11, 2008

Vanderbilt’s Emergency Department to Test All Adult Patients for HIV

This month, Vanderbilt University Medical Center will begin routine and rapid HIV testing of all adults seen in the Emergency Department unless they “opt out” of the procedure.

By Bill Snyder
December 18, 2007

Vanderbilt awarded $4.4 million by the Michael J. Fox Foundation; Goal is to develop new class of Parkinson’s disease drugs

A drug discovery team at Vanderbilt University Medical Center led by Jeffrey Conn has been awarded a $4.4 million “LEAPS” grant by the Michael J. Fox Foundation for Parkinson’s Research to jump-start development of a new class of Parkinson’s diseasedrugs.

By Bill Snyder
May 4, 2006

Aeras and Vanderbilt University Announce License Deal for New TB Vaccine

The Aeras Global TB Vaccine Foundation of Bethesda, Md., and Vanderbilt University of Nashville, Tenn., announced that the two organizations had executed an exclusive license for a tuberculosis vaccine.

By Bill Snyder